These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3214269)
1. Replication of human immunodeficiency virus: yield of infectious virus under single growth cycle conditions. Dianzani F; Antonelli G; Capobianchi MR; De Marco F Arch Virol; 1988; 103(1-2):127-31. PubMed ID: 3214269 [TBL] [Abstract][Full Text] [Related]
2. LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Roos JW; Maughan MF; Liao Z; Hildreth JE; Clements JE Virology; 2000 Aug; 273(2):307-15. PubMed ID: 10915601 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction. Dianzani F; Capobianchi MR; Antonelli G; Amicucci P; De Marco F Antiviral Res; 1989; 11(5-6):299-305. PubMed ID: 2802571 [TBL] [Abstract][Full Text] [Related]
4. MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV). Tateno M; Levy JA Virology; 1988 Nov; 167(1):299-301. PubMed ID: 3263731 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection. Ankel H; Turriziani O; Antonelli G J Gen Virol; 1991 Nov; 72 ( Pt 11)():2797-800. PubMed ID: 1940869 [TBL] [Abstract][Full Text] [Related]
6. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells. Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antiviral effect of new compounds by using cellular cultures. Dianzani F; Antonelli G Cytotechnology; 1991 Feb; 5(Suppl 1):3-6. PubMed ID: 22358940 [TBL] [Abstract][Full Text] [Related]
8. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition of human immunodeficiency virus replication by azidothymidine (Azitidín Lachema) in cultured cells]. Schmidtmayerová H; Mayer V Bratisl Lek Listy; 1993 Feb; 94(2):76-80. PubMed ID: 7689030 [TBL] [Abstract][Full Text] [Related]
10. Concurrent human immunodeficiency virus and mycobacterial infection of macrophages in vitro does not reveal any reciprocal effect. Meylan PR; Munis JR; Richman DD; Kornbluth RS J Infect Dis; 1992 Jan; 165(1):80-6. PubMed ID: 1727900 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of HIV-1 replication and antigen expression in EBV-transformed B cell lines. Tremblay M; Fitz-Gibbon L; Wainberg MA Leukemia; 1988 Dec; 2(12 Suppl):233S-240S. PubMed ID: 2849000 [TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Tersmette M; van Dongen JJ; Clapham PR; de Goede RE; Wolvers-Tettero IL; Geurts van Kessel A; Huisman JG; Weiss RA; Miedema F Virology; 1989 Feb; 168(2):267-73. PubMed ID: 2464872 [TBL] [Abstract][Full Text] [Related]
13. Potential mechanisms for the cytopathic properties of HIV. Garry RF AIDS; 1989 Nov; 3(11):683-94. PubMed ID: 2575911 [No Abstract] [Full Text] [Related]
14. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. Miller MD; Warmerdam MT; Gaston I; Greene WC; Feinberg MB J Exp Med; 1994 Jan; 179(1):101-13. PubMed ID: 8270859 [TBL] [Abstract][Full Text] [Related]
15. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. Nara PL; Hatch WC; Dunlop NM; Robey WG; Arthur LO; Gonda MA; Fischinger PJ AIDS Res Hum Retroviruses; 1987; 3(3):283-302. PubMed ID: 3481271 [TBL] [Abstract][Full Text] [Related]
16. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. Arthos J; Rubbert A; Rabin RL; Cicala C; Machado E; Wildt K; Hanbach M; Steenbeke TD; Swofford R; Farber JM; Fauci AS J Virol; 2000 Jul; 74(14):6418-24. PubMed ID: 10864653 [TBL] [Abstract][Full Text] [Related]
17. Amplification of human immuno-deficiency virus production from a virus-producing cell line in culture at high cell density. Ikuta K; Imai H; Ueda S; Suehiro S; Yamamoto N; Kato S Jpn J Cancer Res; 1987 Jul; 78(7):643-7. PubMed ID: 3114193 [TBL] [Abstract][Full Text] [Related]
18. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. Kornbluth RS; Oh PS; Munis JR; Cleveland PH; Richman DD J Exp Med; 1989 Mar; 169(3):1137-51. PubMed ID: 2466937 [TBL] [Abstract][Full Text] [Related]
19. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Rudensey LM; Kimata JT; Benveniste RE; Overbaugh J Virology; 1995 Mar; 207(2):528-42. PubMed ID: 7886956 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of the replication kinetics in primary culture of isolates of HIV-1 from infected patients in various stages of the disease]. Fiore JR; Angarano G; Fico C; Di Stefano M; Monno L; Pastore G Boll Soc Ital Biol Sper; 1991 May; 67(5):529-34. PubMed ID: 1805885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]